Wyoming MPJE (Pharmacy Jurisprudence) Practice Exam

Which of the following must be included on the label of a compounded sterile product?

1. Batch number, manufacturing date, distributor's name

2. Correct names and strengths of each ingredient, total volume, beyond-use date (BUD), route of administration, storage conditions

3. Date of compounding, compounded by pharmacist's initials, pharmacy logo

4. Ingredients source, compounding time, phone number of the compounding pharmacist

The correct answer is: Correct names and strengths of each ingredient, total volume, beyond-use date (BUD), route of administration, storage conditions

In compounding sterile products, it is crucial to ensure patient safety by providing clear and accurate information on the product label. Option B is correct because it includes essential information that must be included on the label of a compounded sterile product. The correct names and strengths of each ingredient are necessary to ensure that the patient receives the intended medication in the correct dosage. Including the total volume helps in proper dosing administration. The beyond-use date (BUD) is critical for indicating the date until which the product is expected to remain stable and safe for use. The route of administration specifies how the medication should be administered, and storage conditions ensure that the product is stored appropriately to maintain its stability and efficacy. The other options are incorrect because they do not provide a comprehensive list of essential information required on the label of a compounded sterile product. For example: - Option A does not include information such as the beyond-use date (BUD), route of administration, and storage conditions, which are crucial for patient safety. - Option C only includes the date of compounding, compounded by pharmacist's initials, and pharmacy logo, but it lacks important details like ingredient names and strengths, total volume, and storage conditions. - Option D includes some relevant information like ingredient source and compounding time but lacks details such as the correct names and strengths of each ingredient, total volume, and beyond-use date (BUD), which are essential for patient safety and proper use of the medication.